Transepithelial elimination of Monsel's solution-induced granuloma.
D000368:Aged; D002280:Basal Cell Carcinoma / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D004817:Epidermis / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005290:Ferric Compounds / Q000009:adverse effects*; D006099:Granuloma / Q000139:chemically induced / Q000473:pathology*; D006801:Humans; D007501:Iron / Q000009:adverse effects*; D008297:Male; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000473:pathology; D013431:Sulfates / Q000009:adverse effects*
D005290:Ferric Compounds; D013431:Sulfates; C028968:ferric subsulfate solution; D007501:Iron